Utah Medical Products, Inc. (NASDAQ:UTMD) Shares Bought by Geode Capital Management LLC

Geode Capital Management LLC grew its stake in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 9.6% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 97,080 shares of the medical instruments supplier’s stock after buying an additional 8,516 shares during the period. Geode Capital Management LLC’s holdings in Utah Medical Products were worth $6,497,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in UTMD. Copeland Capital Management LLC purchased a new stake in Utah Medical Products during the third quarter valued at about $53,000. BNP Paribas Financial Markets lifted its stake in shares of Utah Medical Products by 102.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 1,117 shares of the medical instruments supplier’s stock valued at $75,000 after purchasing an additional 566 shares in the last quarter. Allspring Global Investments Holdings LLC purchased a new stake in shares of Utah Medical Products during the 2nd quarter worth about $83,000. Victory Capital Management Inc. increased its position in Utah Medical Products by 124.4% during the 2nd quarter. Victory Capital Management Inc. now owns 2,673 shares of the medical instruments supplier’s stock worth $179,000 after purchasing an additional 1,482 shares in the last quarter. Finally, GSA Capital Partners LLP purchased a new position in Utah Medical Products in the third quarter valued at approximately $231,000. 69.60% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, StockNews.com downgraded shares of Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research note on Thursday, November 7th.

Utah Medical Products Price Performance

NASDAQ:UTMD opened at $61.35 on Friday. The business’s 50-day moving average is $64.06 and its two-hundred day moving average is $66.17. The firm has a market capitalization of $208.10 million, a PE ratio of 14.37 and a beta of 0.08. Utah Medical Products, Inc. has a 12 month low of $60.39 and a 12 month high of $85.76.

Utah Medical Products Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, January 3rd. Shareholders of record on Monday, December 16th were issued a $0.305 dividend. This represents a $1.22 dividend on an annualized basis and a yield of 1.99%. The ex-dividend date of this dividend was Monday, December 16th. This is a boost from Utah Medical Products’s previous quarterly dividend of $0.30. Utah Medical Products’s dividend payout ratio is currently 28.57%.

About Utah Medical Products

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.